CIK 0001404281
- Non-accelerated filer
- Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-12-15 | Kalowski Lee Chief Financial Officer | Grant or award · Stock Option (right to buy) | +62,000 | 62,000 | ||
| 2015-09-08 | Kalowski Lee Chief Financial Officer | Sale | −4,668 | $13.13 | $61K | 40,953 |
| 2015-09-02 | Kalowski Lee Chief Financial Officer | Sale | −2,158 | $12.96 | $28K | 45,621 |
| 2015-04-16 | Kalowski Lee Chief Financial Officer | Sale | −4,567 | $13.00 | $59K | 47,779 |
| 2015-04-02 | Kalowski Lee Chief Financial Officer | Sale | −2,258 | $11.45 | $26K | 52,346 |
| 2014-09-17 | Kalowski Lee Chief Financial Officer | Grant or award | +54,604 | 54,604 | ||
| 2014-09-17 | Kalowski Lee Chief Financial Officer | Grant or award · Stock Option (right to buy) | +218,417 | 218,417 |
Page 1 of 1 · 7 trades